2006;151(3):713-719. 99. Lip GY, Frison L, Halperin JL, Lane DA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial brillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol. 2011;57(2):173-180. 100. Holmes DR, Reddy VY, Turi ZG, et al; PROTECT AF Investigators. Percutaneous closure of the left atrial append- age versus warfarin therapy for prevention of stroke in patients with atrial brillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534-542. 101. Ostermayer SH, Reisman M, Kramer PH, et al. Per- cutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial brillation: results from the inter- national multi-center feasibility trials. J Am Coll Cardiol. 2005;46(1):9-14. 102. Block PC, Burstein S, Casale PN, et al. Percutaneous left atrial appendage occlusion for patients in atrial bril- lation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Trans- catheter Occlusion) Study. JACC Cardiovasc Interv. 2009; 2(7):594-600. 103. Lechat P, Lardoux H, Mallet A, et al; FFAACS (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontan ) Investigators. Anticoagulant ( uindione)-aspirin combina- tion in patients with high-risk atrial brillation. A random- ized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontan ; FFAACS). Cerebrovasc Dis. 2001;12(3): 245-252. 104. Flaker GC, Gruber M, Connolly SJ, et al; SPORTIF Investigators. Risks and bene ts of combining aspirin with anticoagulant therapy in patients with atrial brillation: an exploratory analysis of stroke prevention using an oral e574S Antithrombotic Therapy for Atrial Fibrillation of patients before nonanticoagulated cardioversion from atrial brillation and utter: an analysis of pooled trials. Am Heart J. 1995;129(1):71-75. 140. Gallagher MM, Hennessy BJ, Edvardsson N, et al. 